Robert Bruce's ABBV Position Overview
Robert Bruce (via Bruce & Co., Inc.) currently holds 127.5K shares of AbbVie Inc. (ABBV) worth $29.52 M, representing 9.14% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Robert Bruce has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2020, adding 64.7K shares. Largest reduction occurred in Q3 2021, reducing 64.6K shares.
Analysis based on 13F filings available since 2013 Q2
Robert Bruce's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Robert Bruce
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +234,301 | Add 0.00% | 234,300 | $41.34 |
| Q4 2013 | -3,000 | Reduce 1.28% | 231,300 | $52.81 |
| Q4 2014 | +1,615 | Add 0.70% | 232,915 | $65.44 |
| Q1 2018 | +39,000 | Add 16.74% | 271,915 | $94.65 |
| Q2 2019 | -17,115 | Reduce 6.29% | 254,800 | $72.72 |
| Q3 2019 | +3,000 | Add 1.18% | 257,800 | $75.72 |
| Q2 2020 | +64,749 | Add 25.12% | 322,549 | $98.18 |
| Q4 2020 | +5,577 | Add 1.73% | 328,126 | $107.15 |
| Q1 2021 | +40,000 | Add 12.19% | 368,126 | $108.22 |
| Q3 2021 | -64,626 | Reduce 17.56% | 303,500 | $107.87 |
| Q1 2022 | -60,000 | Reduce 19.77% | 243,500 | $162.11 |
| Q2 2022 | -20,000 | Reduce 8.21% | 223,500 | $153.16 |
| Q4 2022 | -21,000 | Reduce 9.40% | 202,500 | $161.61 |
| Q1 2023 | -10,757 | Reduce 5.31% | 191,743 | $159.37 |
| Q3 2023 | -28,743 | Reduce 14.99% | 163,000 | $149.06 |
| Q4 2023 | -25,000 | Reduce 15.34% | 138,000 | $154.97 |
| Q2 2024 | +23,500 | Add 17.03% | 161,500 | $171.52 |
| Q3 2024 | -15,000 | Reduce 9.29% | 146,500 | $197.48 |
| Q4 2024 | -9,000 | Reduce 6.14% | 137,500 | $177.70 |
| Q1 2025 | -10,000 | Reduce 7.27% | 127,500 | $209.52 |
Robert Bruce's AbbVie Investment FAQs
Robert Bruce first purchased AbbVie Inc. (ABBV) in Q2 2013, acquiring 234,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce has held AbbVie Inc. (ABBV) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's largest addition to AbbVie Inc. (ABBV) was in Q2 2013, adding 234,300 shares worth $9.68 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Robert Bruce's firm, Bruce & Co., Inc., owns 127,500 shares of AbbVie Inc. (ABBV), valued at approximately $29.52 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AbbVie Inc. (ABBV) represents approximately 9.14% of Robert Bruce's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Robert Bruce's peak holding in AbbVie Inc. (ABBV) was 368,126 shares, as reported at the end of Q1 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.